Tranexamic Acid + Vitamin C: A Pigmentation Stack That Compounds
Tranexamic acid and vitamin C work on different points in the melanin pathway. Stacking them gives complementary effect for melasma and PIH.
The short answer
Tranexamic acid and vitamin C act on different points in the melanin synthesis pathway. Tranexamic acid blocks plasmin signaling that triggers melanocyte activity (the upstream signal), while vitamin C inhibits tyrosinase (the downstream enzyme converting tyrosine to melanin). Stacking them addresses pigmentation from two angles, with no chemical incompatibility [A17].
How the stack works
Melasma and post-inflammatory hyperpigmentation (the dark marks left after acne or irritation) are driven by overactive melanocytes responding to UV, hormones, or inflammation. The synthesis pathway has multiple control points:
- Signal: UV/inflammation → keratinocytes release plasmin → activates melanocytes
- Synthesis: active melanocyte uses tyrosinase to convert tyrosine → DOPA → melanin
- Transfer: melanin packed into melanosomes → transferred to surrounding keratinocytes
- Visibility: keratinocytes carry melanin to surface as they mature
Tranexamic acid blocks step 1. Vitamin C blocks step 2. Niacinamide (often added as the third) blocks step 3. Each ingredient targets a different control point, so the effects add rather than redundantly stack.
The routine pattern
AM: vitamin C antioxidant serum + sunscreen. Photoprotection is mandatory — every pigmentation pathway works harder if UV continues to drive new pigment.
PM: tranexamic acid serum (typically 2–5%) on clean skin, optionally with niacinamide layered on top. If you're pregnant or breastfeeding, check with your OB before starting tranexamic acid — melasma is often hormone-driven, and safety data on topical tranexamic acid in pregnancy is limited.
Some formulations combine all three (vitamin C + tranexamic + niacinamide); these can be used AM or PM but most users get the cleanest result from the split.
What the evidence actually shows
Topical tranexamic acid for melasma has moderate support at 2–5% on an 8–12 week clock, and it is the less-settled half of this stack: it matched hydroquinone in blinded head-to-head trials [A17] but has not consistently beaten its own base cream [H56]. The combined synergy with vitamin C is documented mechanistically and in small trials but not in large head-to-head comparisons against single-active routines.
The stack is often reached for when pigmentation hasn't budged on vitamin C alone — a dermatologist can confirm whether it's melasma or post-inflammatory darkening, which respond differently.
What it doesn't replace
Daily SPF. UV protection is one of the strongest factors in melasma outcomes — without it, the stack fights upstream against ongoing damage. Tinted mineral sunscreens that also block visible light are often recommended for melasma.
The stack also doesn't replace dermatology evaluation for severe melasma. Hydroquinone, prescription retinoids, and combined topical regimens (Kligman trio) are stronger options for resistant cases — your derm can offer.
When to add tranexamic acid to vitamin C
- Melasma not responding to 12+ weeks of vitamin C + sunscreen alone
- Post-inflammatory hyperpigmentation that's slow to fade
- Stable pigmentation where you want to compound vitamin C's effect
Bottom line
The tranexamic acid + vitamin C stack is one of the cleanest examples of pathway-diversification in cosmetic dermatology. The two ingredients address different parts of the melanin synthesis cascade, so the combination addresses pigmentation from two angles without compounding irritation. Drop's routine engine surfaces the synergy [A17] when both ingredients are in your inventory.
Sources
- [A17]Kim HJ, Moon SH, Cho SH, et al. (2017). Efficacy and Safety of Tranexamic Acid in Melasma: A Meta-analysis and Systematic Review. Acta Dermato-Venereologica. View source ↗Bala HR, Lee S, Wong C, Pandya AG, Rodrigues M (2018). Oral Tranexamic Acid for the Treatment of Melasma: A Review. Dermatologic Surgery. View source ↗Pennitz A, Kinberger M, Avila Valle G, Passeron T, Nast A, Werner RN (2022). Self-applied topical interventions for melasma: a systematic review and meta-analysis of data from randomized, investigator-blinded clinical trials. British Journal of Dermatology. View source ↗
- [H56]Liang J, Chen J, Zhao Z, et al. (2024). Comparative efficacy and safety of tranexamic acid for melasma by different administration methods: A systematic review and network meta-analysis. Journal of Cosmetic Dermatology. View source ↗Kanechorn Na Ayuthaya P, Niumphradit N, Manosroi A, Nakakes A (2012). Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial. Journal of Cosmetic and Laser Therapy. View source ↗